Alembic Pharmaceuticals .'s Stock Falls -3.18% on November 8th, Underperforms Sector Average.

Alembic Pharmaceuticals ., a largecap pharmaceutical company, saw a decline of -3.18% in its stock price on November 8th, 2024. This underperformance was reflected in the stock's performance today, as it fell -2.45% below the sector average. The stock has been on a downward trend for the past two days, with a total loss of -8.16% during this period.

On November 8th, the stock hit an intraday low of Rs 1045.2, representing a -3.06% decrease from its previous closing price. Despite this recent decline, Alembic Pharmaceuticals .'s stock price remains higher than its 200-day moving average, but lower than its 5-day, 20-day, 50-day, and 100-day moving averages.

In comparison to the overall market performance, Alembic Pharmaceuticals .'s stock has underperformed the Sensex by -3.06% on November 8th. Over the past month, the stock has seen a decline of -16.14%, while the Sensex has only decreased by -2.74%.

MarketsMOJO has given a 'Hold' rating for Alembic Pharmaceuticals .'s stock, indicating a neutral stance on its performance. As a largecap company in the pharmaceutical and drugs industry, Alembic Pharmaceuticals . continues to be a key player in the market, with its stock price being closely monitored by investors.